- Home
- U vs NBIX Comparison
U vs NBIX Comparison
Compare U & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | NBIX |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0B | 14.4B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | U | NBIX |
|---|---|---|
| Price | $45.46 | $155.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 19 |
| Target Price | $37.66 | ★ $173.79 |
| AVG Volume (30 Days) | ★ 8.1M | 969.9K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | N/A | ★ 4.19 |
| Revenue | $1,803,658,000.00 | ★ $2,682,700,000.00 |
| Revenue This Year | $3.13 | $23.76 |
| Revenue Next Year | $12.89 | $18.01 |
| P/E Ratio | ★ N/A | $37.10 |
| Revenue Growth | N/A | ★ 19.61 |
| 52 Week Low | $15.33 | $84.23 |
| 52 Week High | $46.94 | $157.67 |
Technical Indicators
Market Signals| Indicator | U | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 65.76 | 64.81 |
| Support Level | $43.51 | $150.26 |
| Resistance Level | $45.66 | $154.35 |
| Average True Range (ATR) | 2.04 | 4.16 |
| MACD | 0.58 | 1.07 |
| Stochastic Oscillator | 90.39 | 93.25 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.